First evidence of glial contribution to the nervous system pathology was provided by a Drosophila model which displayed FRDA-like symptoms and a reduced life-span after targeted suppression of FXN in glial cell lines (Navarro et al., 2010). This evidence concerns the gene FXN and Friedreich ataxia.